Schedule 13D ownership disclosure

LAKEFRONT BIOTHERAPEUTICS NV

Ordinary Shares, no par value · CUSIP: 36315X101

Event date: 2025-05-15

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • EcoR1 Capital, LLCReported CIK 0001587114

    Shares: 7,803,202.00 · Class: 11.84%

  • Oleg NodelmanReported CIK 0001454385

    Shares: 7,803,202.00 · Class: 11.84%

  • EcoR1 Capital Fund Qualified, L.P.Reported CIK 0001598292

    Shares: 7,339,498.00 · Class: 11.14%

  • EcoR1 Capital Fund, L.P.Reported CIK 0001567938

    Shares: 463,704.00 · Class: 0.70%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-045527
Form type
SCHEDULE 13D/A
Filer
EcoR1 Capital, LLC
CIK
CIK 1587114
Filed
May 19, 2025
Reporting period
May 15, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub